Date published: 2026-5-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

AChRβ2 Inhibitors

The Acetylcholine Receptor β2 subunit (AChRβ2) is integral to the functioning of nicotinic acetylcholine receptors (nAChRs), which are pivotal in mediating synaptic transmission through the action of the neurotransmitter acetylcholine (ACh). These receptors are widely distributed across the central and peripheral nervous systems, where they contribute to a variety of physiological processes including neuromuscular transmission, cognitive functions such as learning and memory, and the regulation of neurotransmitter release. The AChRβ2 subunit, in particular, plays a critical role in the assembly and functional properties of nAChRs, contributing to the receptor's ion channel kinetics, ligand-binding affinity, and selective permeability to cations. This subunit's presence in specific receptor subtypes is associated with distinct pharmacological profiles and physiological functions, underscoring its importance in the nuanced regulation of cholinergic signaling. Given its involvement in critical brain functions and the modulation of dopaminergic systems, the AChRβ2 subunit is also implicated in various neurological disorders and conditions related to cognitive function and addiction.

The inhibition of AChRβ2 involves mechanisms that directly or indirectly disrupt the normal action of acetylcholine on its receptors containing the β2 subunit. Inhibition can occur through various means, including the binding of antagonists to the ligand-binding sites, which hinders acetylcholine from activating the receptor, or through allosteric modulation, where the inhibitor binds to a site distinct from the acetylcholine binding site, inducing conformational changes that reduce receptor activity. Additionally, the desensitization of receptors, a process by which prolonged exposure to agonists leads to a decrease in receptor responsiveness, can also function as a form of inhibition. This reduction in AChRβ2 activity can significantly impact neural communication, affecting neurotransmitter release and influencing neurophysiological processes related to learning, memory, and neuromuscular coordination. Understanding the mechanisms underlying the inhibition of AChRβ2 is crucial for elucidating the complex dynamics of cholinergic signaling in the nervous system and for identifying targets for pharmacological intervention in related disorders. However, it's essential to approach the modulation of this target with precision, given its widespread influence on critical aspects of neuronal function and behavior.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hexamethonium bromide

55-97-0sc-205712
sc-205712A
10 g
25 g
$46.00
$64.00
(0)

Hexamethonium acts as a nicotinic receptor antagonist. It can inhibit AChRβ2 by blocking the transmission of nerve impulses in the autonomic ganglia.

Dextromethorphan

125-71-3sc-278927
sc-278927A
sc-278927B
10 g
100 g
500 g
$177.00
$1156.00
$5208.00
3
(1)

Dextromethorphan, commonly used as a cough suppressant, can inhibit nicotinic acetylcholine receptors. It may have an inhibitory effect on AChRβ2, reducing receptor-mediated neurotransmission.